(Press-News.org) Washington, D.C. | 22 January 2026 – Sujuan Ba, CEO of the National Foundation for Cancer Research (NFCR), has been named to OncoDaily’s list of the 100 Most Influential CEOs in Oncology in 2025, recognizing leaders whose work is shaping the global cancer research and care ecosystem.
The annual list honors chief executives across industry, academia, policy, healthcare systems, and mission-driven organizations whose leadership has driven measurable and lasting impact in oncology worldwide. Dr. Ba is recognized alongside leaders from major cancer centers, biopharmaceutical companies, research institutions, and global advocacy organizations.
“I am deeply humbled to be included among such an extraordinary group of leaders from across the entire oncology ecosystem and from every region of the world,” said Dr. Ba. “This recognition reflects not only my role, but the commitment, agility, and mission-driven work of the entire NFCR team as we work to advance cancer research globally.”
Under Dr. Ba’s leadership, NFCR has strengthened its role as a strategic accelerator of cancer research, supporting innovative science, fostering cross-sector collaboration, and addressing systemic challenges facing the research ecosystem. The organization’s work spans basic discovery through translational impact, with a focus on enabling solutions that no single institution can achieve alone.
Dr. Ba emphasized that the recognition is about leadership, not labels. “I am honored to be recognized simply as a leader among leaders,” she said. “This moment underscores the importance of stewardship, collaboration, and accountability in advancing progress against cancer.”
OncoDaily’s 100 Most Influential CEOs in Oncology list highlights leaders whose decisions and vision continue to shape the future of cancer research, care, access, and policy worldwide.
For the full list, visit https://oncodaily.com/100/100-most-influential-ceos-438440.
About the National Foundation for Cancer Research
The National Foundation for Cancer Research (NFCR) is a 501(c)(3) nonprofit organization co-founded in 1973 by Nobel Laureate Dr. Albert Szent-Györgyi and attorney/business entrepreneur Franklin Salisbury, Sr. NFCR provides scientists in the lab with the critical seed funding they need to make game-changing discoveries in cancer detection, treatments, prevention, and ultimately, a cure for all cancers. NFCR has distinguished itself in the cancer research sector by emphasizing “high-risk, high-impact” long-term and transformative pioneering research fields often overlooked by other major funding sources. With the support of more than 5.7 million individual donors over the last 50+ years, NFCR has provided more than $420 million in funding to cancer research, prevention, and public education. NFCR-supported research has led to some of the most significant life-saving discoveries that benefit patients today.
END
National Foundation for Cancer Research CEO Sujuan Ba Named One of OncoDaily’s 100 Most Influential Oncology CEOs of 2025
2026-01-22
ELSE PRESS RELEASES FROM THIS DATE:
New analysis disputes historic earthquake, tsunami and death toll on Greek island
2026-01-22
For decades, researchers thought that an October 1843 earthquake on the small Greek island of Chalke caused a powerful tsunami and led to the deaths of as many as 600 people.
But a new analysis of primary accounts of the event by Ioanna Triantafyllou at Hellenic Mediterranean University suggests the truth was much less dramatic and destructive.
As Triantafyllou reports in Seismological Research Letters, evidence from primary sources indicates that the mainshock occurred on Chalke on 17 September 1843, causing ...
Drexel study finds early intervention helps most autistic children acquire spoken language
2026-01-22
After receiving evidence-based early interventions, roughly two-thirds of non-speaking kids with autism speak single words, and approximately half develop more complex language, according to a new study led by researchers at Drexel University’s A.J. Drexel Autism Institute. The findings, which offer insights that might help improve success rates for the kids who remain non-speaking or minimally speaking (e.g. not combining words to form short phrases) after therapy, were recently published in the Journal of Clinical Child and Adolescent Psychology.
About one in 31 kids in the United States are autistic, according to a 2025 CDC report, a number that ...
Study finds Alzheimer's disease can be evaluated with brain stimulation
2026-01-22
FOR IMMEDIATE RELEASE, January 22, 2026
Contact: Gina DiGravio, 617-358-7838, ginad@bu.edu
Study Finds Alzheimer's Disease Can Be Evaluated with Brain Stimulation
(Boston)—As individuals with Alzheimer’s disease (AD) move from the mild cognitive impairment stage to moderate and severe dementia, complex awareness deteriorates although lower-level sensory awareness is relatively maintained. Most conscious processes also become more impaired as AD progresses, including attention, working memory, episodic memory and executive function, while unconscious processes, such as ...
Cells that are not our own may unlock secrets about our health
2026-01-22
During pregnancy, maternal and fetal cells migrate back and forth across the placenta, with fetal cells entering the mother’s bloodstream and tissues. They can settle in maternal organs such as the thyroid, liver, lungs, brain and heart — and can persist there for decades. Conversely, maternal cells can enter the fetus and be passed down to future generations, essentially creating a lifelong connection between mothers, their offspring and their descendants.
In other words, we all carry little pieces of our family with us.
This phenomenon, called microchimerism, is often characterized by cells of different genetic origin ...
Caring Cross and Boston Children’s Hospital collaborate to expand access to gene therapy for sickle cell disease and beta thalassemia
2026-01-22
Gaithersburg, Maryland and Boston, MA — January 20, 2026 — Caring Cross, a 501(c)(3) non-profit dedicated to improving access to advanced therapies, and Boston Children’s Hospital today announced a collaboration to provide a sustainable, affordable pathway for patients to access stem cell gene therapies for the treatment of Sickle Cell Disease (SCD).
The partnership centers on a worldwide license granted to Caring Cross by Boston Children’s for lentiviral-based BCL11A-LCRshRNAmiR, an innovative technology designed to “flip the switch” on fetal hemoglobin ...
Mount Sinai review maps the path forward for cancer vaccines, highlighting promise of personalized and combination approaches
2026-01-22
NEW YORK, (January 22, 2026) – A new comprehensive review from researchers at the Icahn School of Medicine at Mount Sinai details how decades of cancer vaccine research are converging into a new era of more precise, personalized, and effective immunotherapies, particularly when combined with other cancer treatments.
The review, titled “Pipe Dream to Pipeline: Journey of Cancer Vaccines and the Road Ahead” and published in Cell Reports Medicine, examines the evolution of therapeutic cancer vaccines, with a special focus on neoantigen-based ...
Illinois study: How a potential antibiotics ban could affect apple growers
2026-01-22
URBANA, Ill. – Antibiotic resistance in human and animal health is on the forefront of public debate, but it’s a less well-known issue in plant agriculture. However, antibiotics are important tools in fruit production, and their efficacy hinges on avoiding resistance in disease-causing bacteria.
The U.S. does not currently restrict antibiotics use in fruit orchards, but regulatory measures could occur in the future. A new study from the University of Illinois Urbana-Champaign ...
UC Irvine and Jefferson Health researchers find differences between two causes of heart valve narrowing
2026-01-22
Irvine, Calif., Jan. 22, 2026 — University of California, Irvine and Philadelphia-based Jefferson Health researchers have identified fundamental structural and functional differences between two major causes of mitral valve stenosis. This narrowing restricts blood flow through the heart. The findings challenge current diagnostic approaches and may help clinicians tailor treatment decisions for a growing patient population.
The study, published in the Journal of the American Heart Association, combined 3D ultrasound heart imaging ...
Ancien DNA pushes back record of treponemal disease-causing bacteria by 3,000 years
2026-01-22
Scientists have recovered a genome of Treponema pallidum – the bacterium whose subspecies today are responsible for four treponemal diseases, including syphilis – from 5,500-year-old human remains in Sabana de Bogotá, Colombia. The research expands knowledge about the history of this infectious disease and its occurrence in human populations, with findings now published in the journal Science.
The individual was archaeologically recovered from a rock shelter near Bogotá, Colombia, dating back roughly 5,500 years. The discovery pushes the genetic record of this pathogenic ...
Human penis size influences female attraction and male assessment of rivals
2026-01-22
Men assess potential rivals that have a larger penis as more of a threat, both physically and sexually, according to a study by Upama Aich at the University of Western Australia and colleagues, publishing January 22nd in the open-access journal PLOS Biology.
Relative to body size, the human penis is larger than that of other primates, a fact that has puzzled evolutionary biologists. Before the invention of clothing, the penis would have been a prominent feature that might influence potential mates and ...